Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $319,135 (100.0% shares, 0.0% debt)

Holdings (5)

— DICERNA PHARMACEUTICALS INC 34.3%

Value ($000) $109,395 Shares 8,930,237 Est. Cost $9.03 Unrealized —

— SOLID BIOSCIENCES INC 22.2%

Value ($000) $70,884 Shares 1,989,444 Est. Cost $7.50 Unrealized —

IFRX INFLARX NV 17.8%

Value ($000) $56,955 Shares 1,766,038 Est. Cost $17.97 Unrealized +92.3%

— APTINYX INC 16.9%

Value ($000) $53,780 Shares 2,225,092 Est. Cost $24.17 Unrealized —

— MARINUS PHARMACEUTICALS INC 8.8%

Value ($000) $28,121 Shares 3,977,453 Est. Cost $8.16 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	DICERNA PHARMACEUTICALS INC	8,930,237	$109,395	34.3%	$9.03	—	COM	253031108
—	SOLID BIOSCIENCES INC	1,989,444	$70,884	22.2%	$7.50	—	COM	83422E105
IFRX	INFLARX NV	1,766,038	$56,955	17.8%	$17.97	+92.3%	COM	N44821101
—	APTINYX INC	2,225,092	$53,780	16.9%	$24.17	—	COM	03836N103
—	MARINUS PHARMACEUTICALS INC	3,977,453	$28,121	8.8%	$8.16	—	COM	56854Q101